Novel 3-aryl-2-hydroxypropionic acid derivative for use in conditions associated with insulin resistance and pharmaceutical composition containing same
A novel 3-aryl-2-hydroxypropionic acid derivative, a process and intermediate for it manufacture, pharmaceutical preparations containing it and the use of the compound clinical conditions associated with insulin resistance.